ID: ALA3759686

Max Phase: Preclinical

Molecular Formula: C17H14ClN3OS

Molecular Weight: 343.84

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1sc(NC(=O)Nc2ccc(Cl)cc2)nc1-c1ccccc1

Standard InChI:  InChI=1S/C17H14ClN3OS/c1-11-15(12-5-3-2-4-6-12)20-17(23-11)21-16(22)19-14-9-7-13(18)8-10-14/h2-10H,1H3,(H2,19,20,21,22)

Standard InChI Key:  ZNPBCQNUEYALJJ-UHFFFAOYSA-N

Associated Targets(Human)

SUMO-activating enzyme subunit 1 97 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 343.84Molecular Weight (Monoisotopic): 343.0546AlogP: 5.42#Rotatable Bonds: 3
Polar Surface Area: 54.02Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.38CX Basic pKa: CX LogP: 5.74CX LogD: 5.46
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.67Np Likeness Score: -2.16

References

1. Kumar A, Ito A, Hirohama M, Yoshida M, Zhang KY..  (2016)  Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping.,  26  (4): [PMID:26810265] [10.1016/j.bmcl.2016.01.030]

Source